Robert S. Langer

Last updated

Robert Samuel Langer, Jr.
Robert Langer in 2023.jpg
Langer in 2008
Born (1948-08-29) August 29, 1948 (age 75)
Albany, New York, United States
Other namesBob Langer [1]
Alma mater Cornell University
Massachusetts Institute of Technology
Known forControlled drug delivery and tissue engineering
Awards Gairdner Foundation International Award (1996)
Charles Stark Draper Prize (2002)
John Fritz Medal (2003)
Harvey Prize (2003)
Heinz Award (2004)
Albany Medical Center Prize (2005)
National Medal of Science (2006)
Millennium Technology Prize (2008)
Prince of Asturias Award (2008)
National Medal of Technology and Innovation (2011)
Perkin Medal (2012)
Wilhelm Exner Medal (2012)
Priestley Medal (2012)
Wolf Prize in Chemistry (2013)
IRI Medal (2013)
Breakthrough Prize in Life Sciences (2014)
Kyoto Prize (2014)
Biotechnology Heritage Award (2014)
FREng [2] (2010)
Queen Elizabeth Prize for Engineering (2015)
Kabiller Prize in Nanoscience and Nanomedicine (2017)
Medal of Science (Portugal) (2020)
BBVA Foundation Frontiers of Knowledge Awards (2021)
Balzan Prize (2022)
Scientific career
Fields Chemical Engineering
Biotechnology
Pharmaceuticals
Business
Institutions Massachusetts Institute of Technology
Doctoral advisor Clark K. Colton
Other academic advisors Judah Folkman
Doctoral students W. Mark Saltzman, Erin Lavik, Steven R. Little, Elazer R. Edelman, David J. Mooney, Samir Mitragotri, Mark Prausnitz, Ali Khademhosseini
Other notable students Ronald A. Siegel, Kristi Anseth, David Edwards (engineer), Jennifer Elisseeff, Omid Cameron Farokhzad, Linda Griffith, Guadalupe Hayes-Mota, Jeffrey Karp, Cato Laurencin, Christine E. Schmidt, Robert J. Linhardt, Antonios Mikos, Gordana Vunjak-Novakovic, David Berry, Isaac Berzin, Kathryn Uhrich, Joseph Kost, Akhilesh K. Gaharwar, Molly Stevens, Princess Imoukhuede, Guillermo Ameer, Canan Dağdeviren, Laura Niklason, María José Alonso, Jennifer Elisseeff, Kaitlyn Sadtler, Shiva Ayyadurai
External videos
Robert Langer BioTech Awards Video laboratory.png
Nuvola apps kaboodle.svg Scientists You Must Know: Robert Langer, You want to put yourself in the position where you'll make the discoveries for tomorrow, Science History Institute
Nuvola apps kaboodle.svg Hundreds of millions of people a year across the world benefit from the technologies that rest on the work of Robert Langer., Queen Elizabeth Prize for Engineering 2015

Robert Samuel Langer Jr. FREng [2] (born August 29, 1948) is an American biotechnologist, businessman, chemical engineer, chemist, and inventor. He is one of the nine Institute Professors at the Massachusetts Institute of Technology. [3]

Contents

He was formerly the Germeshausen Professor of Chemical and Biomedical Engineering and maintains activity in the Department of Chemical Engineering and the Department of Biological Engineering at MIT. He is also a faculty member of the Harvard–MIT Program in Health Sciences and Technology and the Koch Institute for Integrative Cancer Research.

Langer holds over 1,400 granted or pending patents. [4] He is one of the world's most highly cited researchers and his h-index is now (according to Google Scholar, 2023-09-16) 320 with currently over 413,000 citations. [5] He is a widely recognized and cited researcher in biotechnology, especially in the fields of drug delivery systems and tissue engineering. [4] [6] [7]

He is the most cited engineer in history [8] and 4th most cited individual in any field, [9] having authored over 1,500 scientific papers. Langer is also a prolific businessman, having been behind the participation in the founding of over 40 biotechnology companies including the well-known American pharmaceutical company, Moderna.

Langer's research laboratory at MIT is the largest biomedical engineering lab in the world; maintaining over $10 million in annual grants and over 100 researchers. [10] He has been awarded numerous leading prizes in recognition of his work.

Background and personal life

Langer was born August 29, 1948, in Albany, New York.

He is an alumnus of The Milne School and received his bachelor's degree from Cornell University in chemical engineering. He earned his Sc.D. in chemical engineering from Massachusetts Institute of Technology in 1974. His dissertation was entitled "Enzymatic regeneration of ATP" and completed under the direction of Clark K. Colton. From 1974–1977 he worked as a postdoctoral fellow at the Children's Hospital Boston and at Harvard Medical School under Judah Folkman. [11]

Contributions to medicine and biotechnology

Langer is widely regarded for his contributions to medicine and biotechnology. [12] He is considered a pioneer of many new technologies, including controlled release systems and transdermal delivery systems, which allow the administration of drugs or extraction of analytes from the body through the skin without needles or other invasive methods. [13] [14] [15]

Langer worked with Judah Folkman at Boston Children's Hospital to isolate the first angiogenesis inhibitor, a macromolecule to block the spread of blood vessels in tumors. [12] [16] Macromolecules tend to be broken down by digestion and blocked by body tissues if they are injected or inhaled, so finding a delivery system for them is difficult. Langer's idea was to encapsulate the angiogenesis inhibitor in a noninflammatory synthetic polymer system that could be implanted in the tumor and control the release of the inhibitor. He eventually invented polymer systems that would work. This discovery is considered to lay the foundation for much of today's drug delivery technology. [12] [17]

Langer also worked with Henry Brem of the Johns Hopkins University Medical School on a drug-delivery system for the treatment of brain cancer, to deliver chemotherapy directly to a tumor site. The wafer implants that he and his teams have designed have become increasingly more sophisticated, and can now deliver multiple drugs, and respond to stimuli. [18] In 2019, he and his team developed and patented a technique whereby microneedle tattoo patches could be used to label people with invisible ink to store medical information subcutaneously. This was presented as a boon to "developing nations" where lack of infrastructure means an absence of medical records. [19] [20] The technology uses a "quantum dot dye that is delivered, along with a vaccine, by a microneedle patch." [19]

Langer is regarded as the founder of tissue engineering in regenerative medicine. [21] He and the researchers in his lab have made advances in tissue engineering, such as the creation of engineered blood vessels and vascularized engineered muscle tissue. [22] [23] Bioengineered synthetic polymers provide a scaffolding on which new skin, muscle, bone, and entire organs can be grown. With such a substrate in place, victims of serious accidents or birth defects could more easily grow missing tissue. [18] [24] Such polymers can be biocompatible and biodegradable. [25]

Langer is involved in several projects related to diabetes. [26] Alongside Daniel G. Anderson, he has contributed bioengineering work to a project involving teams from MIT, Harvard University and other institutions, to produce an implantable device to treat type 1 diabetes by shielding insulin-producing beta cells from immune system attacks. [27] [28] He is also part of a team at MIT that have developed a drug capsule that could be used to deliver oral doses of insulin to people with type 1 diabetes. [29] [30]

Awards and honors

Langer is the youngest person in history (at 43) to be elected to all three American science academies: the National Academy of Sciences, the National Academy of Engineering and the National Academy of Medicine. He was also elected as a charter member of National Academy of Inventors. [31] He was elected as an International Fellow [2] of the Royal Academy of Engineering [2] in 2010.

Langer has received more than 220 major awards. He is one of three living individuals to have received both the U.S. National Medal of Science and the National Medal of Technology and Innovation. [32]

He has received numerous other awards, including the 10th Annual Heinz Award in the category of Technology, the Economy and Employment (2003), [38] [74] In 2013 he was awarded the IRI Medal alongside long-time friend George M. Whitesides for outstanding accomplishments in technological innovation that have contributed broadly to the development of industry and the benefit of society. [75] [76] He also received the Rusnano prize that year. [77]

Langer has honorary degrees from 41 universities from around the world including Harvard, Yale, and Columbia University. [78]

Business ventures

Langer has been involved in the founding of many companies, [79] more than twenty in partnership with the venture capital firm Polaris Partners. [1] Success of these companies and Langer's contribution has been detailed by Harvard Business Review: [80]

Langer is a member of the Advisory Board of Patient Innovation, a nonprofit, international, multilingual, free venue for patients and caregivers of any disease to share their innovations. [88] He is also a member of the Xconomists, an ad hoc team of editorial advisors for the tech news and media company, Xconomy. [89]

Related Research Articles

<span class="mw-page-title-main">George M. Whitesides</span> American chemist

George McClelland Whitesides is an American chemist and professor of chemistry at Harvard University. He is best known for his work in the areas of nuclear magnetic resonance spectroscopy, organometallic chemistry, molecular self-assembly, soft lithography, microfabrication, microfluidics, and nanotechnology. A prolific author and patent holder who has received many awards, he received the highest Hirsch index rating of all living chemists in 2011.

<span class="mw-page-title-main">Carolyn Bertozzi</span> American chemist (born 1966)

Carolyn Ruth Bertozzi is an American chemist and Nobel laureate, known for her wide-ranging work spanning both chemistry and biology. She coined the term "bioorthogonal chemistry" for chemical reactions compatible with living systems. Her recent efforts include synthesis of chemical tools to study cell surface sugars called glycans and how they affect diseases such as cancer, inflammation, and viral infections like COVID-19. At Stanford University, she holds the Anne T. and Robert M. Bass Professorship in the School of Humanities and Sciences. Bertozzi is also an Investigator at the Howard Hughes Medical Institute (HHMI) and is the former director of the Molecular Foundry, a nanoscience research center at Lawrence Berkeley National Laboratory.

<span class="mw-page-title-main">Nicholas A. Peppas</span> Greek chemical and biomedical engineer (b. 1948)

Nicholas (Nikolaos) A. Peppas is a chemical and biomedical engineer whose leadership in biomaterials science and engineering, drug delivery, bionanotechnology, pharmaceutical sciences, chemical and polymer engineering has provided seminal foundations based on the physics and mathematical theories of nanoscale, macromolecular processes and drug/protein transport and has led to numerous biomedical products or devices.

Kristi S. Anseth is the Tisone Distinguished Professor of Chemical and Biological Engineering, an Associate Professor of Surgery, and a Howard Hughes Medical Investigator at the University of Colorado at Boulder. Her main research interests are the design of synthetic biomaterials using hydrogels, tissue engineering, and regenerative medicine.

<span class="mw-page-title-main">Gordana Vunjak-Novakovic</span> Serbian American engineer

Gordana Vunjak-NovakovicFRSC is a Serbian American biomedical engineer and university professor. She is a University Professor at Columbia University, as well as the Mikati Foundation Professor of Biomedical Engineering and Medical Sciences. She also heads the laboratory for Stem Cells and Tissue Engineering at Columbia University. She is part of the faculty at the Irving Comprehensive Cancer Center and the Center for Human Development, both found at Columbia University. She is also an honorary professor at the Faculty of Technology and Metallurgy at the University of Belgrade, an honorary professor at the University of Novi Sad, and an adjunct professor at the Department of Biomedical Engineering at Tufts University.

<span class="mw-page-title-main">Samir Mitragotri</span> American chemist (born 1971)

Samir Mitragotri is an Indian American professor at Harvard University, an inventor, an entrepreneur, and a researcher in the fields of drug delivery and biomaterials. He is currently the Hiller Professor of Bioengineering and Hansjörg Wyss Professor of Biologically Inspired Engineering at Harvard John A. Paulson School of Engineering and Applied Sciences and the Wyss Institute for Biologically Inspired Engineering. Prior to 2017, he was the Duncan and Suzanne Mellichamp Chair Professor at University of California, Santa Barbara.

<span class="mw-page-title-main">Jeffrey Karp</span> Canadian biomedical engineer

Jeffrey Karp is a Canadian biomedical engineer working as a Professor of Medicine at Harvard Medical School, Brigham and Women's Hospital, and the principal faculty at the Harvard Stem Cell Institute and Affiliate Faculty at the Massachusetts Institute of Technology through the Harvard–MIT Division of Health Sciences and Technology. He is also an affiliate faculty at the Broad Institute.

<span class="mw-page-title-main">Paula T. Hammond</span> American chemical engineer (born 1963)

Paula Therese Hammond is a David H. Koch Professor in Engineering and the Head of the Department of Chemical Engineering at the Massachusetts Institute of Technology (MIT). She was the first woman and person of color appointed as head of the Chemical Engineering department. Her laboratory designs polymers and nanoparticles for drug delivery and energy-related applications including batteries and fuel cells.

Martina Heide Stenzel is a Professor in the Department of Chemistry at the University of New South Wales (UNSW). She is also a Royal Australian Chemical Institute (RACI) University Ambassador. She became editor for the Australian Journal of Chemistry in 2008 and has served as Scientific Editor and as of 2021, as Editorial Board Chair of RSC Materials Horizons.

Molly S. Shoichet, is a Canadian science professor, specializing in chemistry, biomaterials and biomedical engineering. She was Ontario's first Chief Scientist. Shoichet is a biomedical engineer known for her work in tissue engineering, and is the only person to be a fellow of the three National Academies in Canada.

William Mark Saltzman was named the Goizueta Foundation Professor of Biomedical and Chemical Engineering at Yale University on July 1, 2002 and became the founding chair of Yale's Department of Biomedical Engineering in 2003. Saltzman's research aims to promote new methods for drug delivery and develop new biotechnologies to combat human disease. A pioneer in the fields of biomaterials, nanobiotechnology, and tissue engineering, Saltzman has contributed to the design and implementation of a number of clinical technologies that have become essential to medical practice today. His popular course Frontiers of Biomedical Engineering is available to everyone through Open Yale Courses.

Elazer R. Edelman is an American engineer, scientist and cardiologist. He is the Edward J. Poitras Professor in Medical Engineering and Science at the Massachusetts Institute of Technology (MIT), Professor of Medicine at Harvard Medical School and at Brigham and Women's Hospital (BWH), and a practicing cardiologist at BWH. He is the director of MIT's Institute for Medical Engineering and Science (IMES), the Harvard-MIT Biomedical Engineering Center, and the MIT Clinical Research Center. He is also the Program Director of the MIT Graduate Education in Medical Sciences program within the Harvard-MIT Division of Health Sciences and Technology.

<span class="mw-page-title-main">Joseph Kost</span> Chemical engineering researcher

Joseph Kost is an Israeli academic, currently holder of The Abraham and Bessie Zacks Chair in Biomedical Engineering and the past Dean of the Faculty of Engineering Sciences at the Ben-Gurion University of the Negev.

Klavs Flemming Jensen is a chemical engineer who is currently the Warren K. Lewis Professor at the Massachusetts Institute of Technology (MIT).

Erin Baker Lavik is a professor of chemical, biochemical, and environmental engineering at the University of Maryland, Baltimore County. Lavik develops polymers and nanoparticles that can protect the nervous system. She is a Fellow of the American Institute for Medical and Biological Engineering.

<span class="mw-page-title-main">Debra Auguste</span> American chemical engineer

Debra Auguste is an American chemical engineer and professor at Northeastern University in the department of chemical engineering. Auguste is dedicated to developing treatments for triple negative breast cancer, one of the most aggressive and fatal cancers that disproportionately affects African American women. Her lab characterizes biomarkers of triple negative breast cancer and develops novel biocompatible therapeutic technologies to target and destroy metastatic cancer cells. Auguste received the 2012 Presidential Early Career Award for Scientists and Engineers and in 2010 was named in the 50 Most Influential African-Americans in Technology. In 2020, Auguste became an Elected Fellow of the American Institute for Medical and Biological Engineering.

<span class="mw-page-title-main">Milica Radisic</span> Serbian Canadian tissue engineer

Milica Radisic is a Serbian Canadian tissue engineer, academic and researcher. She is a professor at the University of Toronto’s Institute of Biomaterials and Biomedical Engineering, and the Department of Chemical Engineering and Applied Chemistry. She co-founded TARA Biosystems and is a senior scientist at the Toronto General Hospital Research Institute.

<span class="mw-page-title-main">Mark Prausnitz</span> Chemical engineer

Mark Robert Prausnitz is an American chemical engineer, currently Regents’ Professor and J. Erskine Love, Jr. Chair in Chemical & Biomolecular Engineering at the Georgia Institute of Technology. He also serves as adjunct professor of biomedical engineering at Emory University and Adjunct Professor of Chemical & Biomolecular Engineering at the Korea Advanced Institute of Science and Technology. He is known for pioneering microneedle technology for minimally invasive drug and vaccine administration, which has found applications in transdermal, ocular, oral, and sustained release delivery systems.

<span class="mw-page-title-main">Liangfang Zhang</span> Chinese-American nanoengineer

Liangfang Zhang is a Chinese-American nanoengineer. He is the Chancellor Professor of Nanoengineering and Bioengineering and Director of Chemical Engineering at the University of California, San Diego. Zhang is a Fellow of the American Institute for Medical and Biological Engineering, American Association for the Advancement of Science, and the National Academy of Inventors.

Christopher A. Alabi is an American chemist and associate professor of chemistry at Cornell University. His research considers the design of sustainable materials and biomolecular therapeutics. He was elected to the American Institute for Medical and Biological Engineering in 2023.

References

  1. 1 2 3 4 Mcguire, Terry (July 1, 2019). "The Many Shades Of VC/Repeat Entrepreneur Relationships". Life Science Leader. Pennsylvania, United States: VertMarkets.
  2. 1 2 3 4 5 6 "List of Fellows". Archived from the original on June 8, 2016. Retrieved October 28, 2014.
  3. Seligson, Hannah (November 24, 2012). "Hatching Ideas, and Companies, by the Dozens at M.I.T." New York Times . Retrieved November 26, 2012. A chemical engineer by training, Dr. Langer has helped start 25 companies and has 811 patents, issued or pending, to his name. ...
  4. 1 2 Robert S. Langer publications indexed by Google Scholar OOjs UI icon edit-ltr-progressive.svg
  5. "Robert Langer". scholar.google.com. Retrieved September 16, 2023.
  6. "1040 Highly Cited Researchers (h>100) according to their Google Scholar Citations public profiles" . Retrieved May 25, 2016.
  7. 1 2 Shukman, David (February 3, 2015). "Drug-delivery pioneer wins £1m engineering prize". BBC News Science & Environment. Retrieved February 3, 2015.
  8. Gura, T. (2014). "The art of entrepreneurship". Science. 346 (6213): 1146. Bibcode:2014Sci...346.1146G. doi: 10.1126/science.346.6213.1146 . PMID   25430772.
  9. "Highly Cited Researchers – 2024". World Scientist and University Rankings – AD Scientific Index 2024.
  10. O'Neill, Kathryn M. (July 20, 2006). "Colleagues honor Langer for 30 years of innovation". MIT News. Retrieved February 6, 2014.
  11. "Robert S. Langer, Sc.D." Academy of Achievement.
  12. 1 2 3 Pearson, Helen (March 4, 2009). "Profile: Being Bob Langer". Nature. 458 (7234): 22–24. doi: 10.1038/458022a . PMID   19262647.
  13. Mitragotri, S; Blankschtein, D; Langer, R (1995). "Ultrasound-mediated transdermal protein delivery". Science. 269 (5225): 850–3. Bibcode:1995Sci...269..850M. doi:10.1126/science.7638603. PMID   7638603. S2CID   26069484.
  14. Kost, J; Mitragotri, S; Gabbay, RA; Pishko, M; Langer, R (2000). "Transdermal monitoring of glucose and other analytes using ultrasound". Nature Medicine. 6 (3): 347–50. doi:10.1038/73213. PMID   10700240. S2CID   31949252.
  15. Langer, Robert; Folkman, Judah (October 1976). "Polymers for the sustained release of proteins and other macromolecules". Nature. 263 (5580): 797–800. Bibcode:1976Natur.263..797L. doi:10.1038/263797a0. PMID   995197. S2CID   4210402.
  16. Cooke, Robert; Koop, C Everett (2001). Dr. Folkman's War: Angiogenesis and the Struggle to Defeat Cancer. New York: Random House. ISBN   978-0-375-50244-6.
  17. National Academy of Science report Beyond Discovery: Polymer and People 1999
  18. 1 2 "Robert S. Langer". Science History Institute. June 2016. Retrieved March 20, 2018.
  19. 1 2 Trafton, Anne (December 18, 2019). "Storing medical information below the skin's surface". MIT News.
  20. Jaklenec, Ana; McHugh, Kevin J.; Langer, Robert S. "Microneedle tattoo patches and use thereof". No. US20190015650A1. US Patent and Trademark Office.
  21. Schilling, David Russell (February 15, 2013). "Langer Profile. Engineering Synthetic Skin". Industry Tap into News. Retrieved February 6, 2014.
  22. Niklason, LE; Gao, J; Abbott, WM; Hirschi, KK; Houser, S; Marini, R; Langer, R (1999). "Functional arteries grown in vitro". Science. 284 (5413): 489–93. Bibcode:1999Sci...284..489N. doi:10.1126/science.284.5413.489. PMID   10205057.
  23. Levenberg, S; Rouwkema, J; MacDonald, M; Garfein, ES; Kohane, DS; Darland, DC; Marini, R; Van Blitterswijk, CA; et al. (2005). "Engineering vascularized skeletal muscle tissue" (PDF). Nature Biotechnology. 23 (7): 879–84. doi:10.1038/nbt1109. PMID   15965465. S2CID   28136064.
  24. Vacanti, Joseph P; Langer, Robert (July 1999). "Tissue engineering: the design and fabrication of living replacement devices for surgical reconstruction and transplantation". The Lancet. 354: S32–S34. doi:10.1016/s0140-6736(99)90247-7. PMID   10437854. S2CID   33614316 . Retrieved February 6, 2014.
  25. Freed, Lisa E.; Vunjak-Novakovic, Gordana; Biron, Robert J.; Eagles, Dana B.; Lesnoy, Daniel C.; Barlow, Sandra K.; Langer, Robert (July 1994). "Biodegradable Polymer Scaffolds for Tissue Engineering". Bio/Technology. 12 (7): 689–693. doi:10.1038/nbt0794-689. PMID   7764913. S2CID   22968473.
  26. Schaffer, Amanda. "Engineering Drug Delivery and Tissue Growth". MIT Technology Review. Retrieved March 21, 2019.
  27. "Potential diabetes treatment advances". Harvard Gazette. January 25, 2016. Retrieved March 21, 2019.
  28. Anderson, Daniel G.; Langer, Robert; Melton, Douglas A.; Weir, Gordon C.; Greiner, Dale L.; Oberholzer, Jose; Hollister-Lock, Jennifer; Bochenek, Matthew A.; McGarrigle, James J. (January 25, 2016). "Long-term glycemic control using polymer-encapsulated human stem cell–derived beta cells in immune-competent mice". Nature Medicine. 22 (3): 306–311. doi:10.1038/nm.4030. ISSN   1546-170X. PMC   4825868 . PMID   26808346.
  29. "New pill can deliver insulin". MIT News. February 7, 2019. Retrieved March 21, 2019.
  30. "Researchers develop a drug capsule that could be used to deliver oral doses of insulin". TechGenYZ. February 9, 2019. Retrieved March 21, 2019.
  31. Lowry, Judy (January 8, 2013). "National Academy of Inventors congratulates NAI Fellows Robert Langer and Leroy Hood, and NAI Member James Wynne on receiving U.S. National Medals". USF Research News. Retrieved February 6, 2014.
  32. 1 2 "Biotechnology Heritage Award". Science History Institute . May 31, 2016. Retrieved February 21, 2018.
  33. "R.S. Langer to receive 1996 Gairdner Award". MIT News. January 24, 1996. Retrieved February 5, 2014.
  34. "Half Million Dollar Lemelson-MIT Prize Winner Announced". Lemelson-MIT. April 15, 1998. Archived from the original on March 6, 2003. Retrieved February 5, 2014.
  35. "Past Winners of the Othmer Gold Medal". Science History Institute. May 31, 2016. Retrieved March 20, 2018.
  36. "Robert S. Langer Receives 2002 Charles Stark Draper Prize from National Academy of Engineering". Journal of Investigative Medicine. 50 (3): 159–160. 2002. doi:10.2310/6650.2002.33415. S2CID   219540335.
  37. "Robert S. Langer, Sc.D. Biography and Interview". www.achievement.org. American Academy of Achievement.
  38. 1 2 "MIT's Langer wins two prestigious prizes". MIT News. December 2, 2003. Archived from the original on February 22, 2014. Retrieved February 5, 2014.
  39. "Laureates 2005: Robert Langer". Dan David Prize. Retrieved February 6, 2014.
  40. McGarry, Greg (April 29, 2005). "MIT Researcher and Albany Native Who Pioneered New Methods for Drug Delivery Named Recipient of America's Top Prize in Medicine". Albany Medical Center. Retrieved February 5, 2014.
  41. National Medal of Science 2006
  42. "Max Planck Research Award". Archived from the original on May 2, 2015. Retrieved June 10, 2014.
  43. "PRINCE OF ASTURIAS AWARD FOR TECHNICAL & SCIENTIFIC RESEARCH 2008" . Retrieved June 10, 2014.
  44. Lau, Thomas (June 11, 2008). "2008 Millennium Technology Prize Awarded to Professor Robert Langer for Intelligent Drug Delivery". European Science Foundation. Archived from the original on February 21, 2014. Retrieved February 6, 2014.
  45. "And the winners were…". The Economist. December 3, 2011. Retrieved February 6, 2014.
  46. "2011 recipients" . Retrieved June 10, 2014.
  47. "Past Perkin Medalists". SCI America. Retrieved February 21, 2018.
  48. "Biopolymer innovator Robert Langer receives 2012 Perkin Medal". SCI. November 8, 2012. Retrieved December 10, 2014.
  49. "SCI Perkin Medal". Science History Institute . May 31, 2016. Retrieved March 24, 2018.
  50. Editor, ÖGV. (2015). Wilhelm Exner Medal. Austrian Trade Association. ÖGV. Austria.
  51. Ritter, Steve (2011). "Robert Langer Named Priestley Medalist". Chemical & Engineering News . 89 (24): 7. doi:10.1021/cen-v089n024.p007.
  52. Landergan, Katherine (January 4, 2013). "M.I.T. professor to be honored by President Obama". MIT. Retrieved February 6, 2014.
  53. "Two MIT professors win prestigious Wolf Prize Michael Artin and Robert Langer honored for groundbreaking work in mathematics and chemistry". MIT News. January 4, 2013. Retrieved February 5, 2014.
  54. "Laureates: 2014". Breakthrough Prize in Life Sciences.
  55. Kaufman, Melanie Miller. "Robert Langer wins 2014 Breakthrough Prize in Life Sciences". MIT News. Retrieved February 6, 2014.
  56. "MIT biomedical engineer Robert Langer wins $500,000 Kyoto Prize". The Boston Globe .
  57. "QEPrize Winner 2015 – Robert Langer". Queen Elizabeth Prize for Engineering. Archived from the original on December 21, 2021. Retrieved February 3, 2015.
  58. "Entrepreneurship at Cornell" . Retrieved August 20, 2015.
  59. "The Scheele Symposium 2015". Läkemedelsakademin. Archived from the original on November 28, 2015. Retrieved November 18, 2016.
  60. Administrator. "Kazemi Prize 2015 Will Be Awarded to Professor Robert S. Langer – Royan Institute". www.royaninstitute.org. Retrieved January 5, 2018.
  61. "Robert S. Langer". ASME. Retrieved June 6, 2017.
  62. "Robert Langer (USA)". www.epo.org. Retrieved May 11, 2021.
  63. "The 2016 Franklin Institute Awards Laureates | MIT Department of Biological Engineering". be.mit.edu. Retrieved January 5, 2018.
  64. "Kabiller Prize & Award".
  65. Huggett, Brady; Paisner, Kathryn (December 8, 2017). "Top 20 translational researchers of 2016". Nature Biotechnology. 35 (12): 1126. doi:10.1038/nbt.4028. PMID   29220038. S2CID   205285596.
  66. Huggett, Brady; Paisner, Kathryn (2018). "Top 20 translational researchers of 2017". Nature Biotechnology. 36 (9): 798. doi: 10.1038/nbt.4237 . PMID   30188525.
  67. 1 2 "School of Engineering third quarter 2018 awards". MIT News. October 19, 2018. Retrieved March 21, 2019.
  68. "2019 Honorees". The Hope Funds for Cancer Research. May 19, 2019. Retrieved July 19, 2019.
  69. "Welcome" . Retrieved October 23, 2019.
  70. "Robert Langer, 2019 | Dreyfus Foundation" . Retrieved July 19, 2019.
  71. "Maurice-Marie JANOT Award – APGI". www.apgi.org/. Retrieved September 21, 2020.
  72. BBVA Foundation Frontiers of Knowledge Awards 2021
  73. "I vincitori dei Premi Balzan 2022". September 12, 2022.
  74. "Robert Langer". The Heinz Awards. Retrieved February 6, 2014.
  75. Wang, Linda (May 28, 2013). "Industrial Research Institute Medal Awarded To Robert S. Langer And George M. Whitesides". Chemical & Engineering News. Archived from the original on February 21, 2014. Retrieved February 5, 2014.
  76. "IRI to recognize George Whitesides, Robert Langer with top award". R&D Magazine. April 17, 2013. Retrieved February 5, 2014.
  77. "Langer receives 2013 Rusnano prize". Archived from the original on July 23, 2014. Retrieved June 17, 2014.
  78. "Langer Lab: Professor Robert Langer". MIT. Retrieved February 6, 2014.
  79. Huang, Gregory T. (April 19, 2011). "The Bob Langer and Polaris Family Tree: From Acusphere to Momenta to Visterra". Xconomy. Retrieved February 6, 2014.
  80. Prokesch, Steven T. (March–April 2017). "The Edison of Medicine". Harvard Business Review. Retrieved March 27, 2017.
  81. Farrell, Michael B. (December 10, 2013). "MIT's Robert Langer has another startup". The Boston Globe. Retrieved February 6, 2014.
  82. Malloy, Shawn. (January 25, 2023). "Robert S. Langer, Co-Founder of Moderna, Joins Lindus Health's Advisory Board". PR Newswire. Retrieved January 25, 2023.
  83. Jones, Vanessa E. (April 2, 2009). "Call him the frizz fighter". The Boston Globe. Retrieved February 6, 2014.
  84. "Shire picks up Pervasis in potential $200M deal" . Retrieved June 10, 2014.
  85. Gormley, Brian (June 26, 2012). "Semprus BioSciences Acquired by Teleflex for Up To $80M in Cash, Milestones". Wall Street Journal. Archived from the original on July 14, 2014. Retrieved June 10, 2014.
  86. "SQZ Biotech – Board of Directors". Archived from the original on March 9, 2014. Retrieved March 8, 2014.
  87. "Johnson & Johnson Completes Acquisition of TransForm Pharmaceuticals, Inc". Archived from the original on May 5, 2011. Retrieved June 10, 2014.
  88. "Who we are | Patient Innovation". March 26, 2014.
  89. "About Our Mission, Team, and Editorial Ethics". Xconomy. Retrieved January 2, 2018.
Awards
Preceded by Millennium Technology Prize winner
2008 (for Innovative biomaterials)
Succeeded by